Updates

OCI Closes U.S. DSCSA Compliance Gap with an Industry-First
OCI News Sanem Berfin İlhan OCI News Sanem Berfin İlhan

OCI Closes U.S. DSCSA Compliance Gap with an Industry-First

OCI invites pharmaceutical supply chain actors into its Early Adopter Program to trial the industry’s first compliance solution for U.S. DSCSA Authorized Trading Partner authentication. The launch of the program now makes the industry’s first functional, scalable solution widely available enabling U.S. supply chain actors to become DSCSA-compliant well ahead of the deadline.

Read More
Open Credentialing Initiative (OCI) Gains Momentum Supporting DSCSA Compliance for Authorized Trading Partners
OCI News Sanem Berfin İlhan OCI News Sanem Berfin İlhan

Open Credentialing Initiative (OCI) Gains Momentum Supporting DSCSA Compliance for Authorized Trading Partners

OCI, a collaborative industry effort, issued a call for the pharmaceutical industry to align on core standards around Authorized Trading Partner (ATP) authentication in compliance with the Drug Supply Chain Security Act (DSCSA). Formed by a group of trading partners, solution providers, and standards organizations, OCI is charting the course for ATP interoperability by 2023.

Read More